Edition:
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

KP Tissue Inc gives Q3 2014 EBITDA guidance


Wednesday, 13 Aug 2014 07:00am EDT 

KP Tissue Inc:Expects EBITDA for Q3 2014 to be higher than Q2 2014 and similar to or slightly higher than Q3 2013. 

Related Company News

Company Quote

11.87
0.08 +0.68%
3:02pm EDT